Edition:
United States

Sangamo BioSciences Inc (SGMO.OQ)

SGMO.OQ on NASDAQ Stock Exchange Global Select Market

2.88USD
9:56am EST
Change (% chg)

$-0.12 (-4.17%)
Prev Close
$3.00
Open
$2.90
Day's High
$2.92
Day's Low
$2.88
Volume
27,974
Avg. Vol
203,497
52-wk High
$9.90
52-wk Low
$2.88

SGMO.OQ

Chart for SGMO.OQ

About

Sangamo Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is focused on research, development and commercialization of engineered deoxyribonucleic acid (DNA)-binding proteins for therapeutic genome editing and gene regulation. It is engaged in developing zinc finger DNA-binding proteins (ZFP) therapeuti... (more)

Overall

Beta: 3.28
Market Cap(Mil.): $211.87
Shares Outstanding(Mil.): 70.62
Dividend: --
Yield (%): --

Financials

  SGMO.OQ Industry Sector
P/E (TTM): -- 42.12 30.77
EPS (TTM): -1.08 -- --
ROI: -42.07 -0.81 15.23
ROE: -43.78 -1.52 16.56

BRIEF-Sangamo Bio sees FY 2016 revenue $12 million to $17 million

* Sangamo biosciences reports second quarter 2016 financial results

Aug 03 2016

BRIEF-Sangamo BioSciences announces FDA clearance

* To initiate SB-913-1602 clinical study for MPS II in second half of 2016

Jun 20 2016

Competitors

  Price Chg
Novo Nordisk A/S (NOVOb.CO) kr.242.60 +2.70
Pfizer Inc. (PFE.N) $30.83 -0.73
Novartis AG (NOVN.S) CHF68.80 -0.60
Merck & Co., Inc. (MRK.N) $59.16 -1.12
Roche Holding Ltd. (ROG.S) CHF221.40 -2.10
Roche Holding Ltd. (RO.S) CHF225.10 -3.10
Bayer AG (BAYGn.DE) €90.06 +1.90
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.07 -0.48
GlaxoSmithKline plc (GSK.L) 1,459.00p -1.00

Earnings vs. Estimates